Area of research
Neurology · Molecular Biology
Research interest
Research interests include Prion Diseases and Protein Misfolding, Neurological diseases and metabolism, Parkinson's Disease Mechanisms and Treatments, and Alzheimer's disease research and treatments.
A comparison of p‐tau assays for the specificity to detect tau changes in Alzheimer's disease
Depressive Symptoms and Amyloid Pathology
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
Duodenal <scp>alpha‐Synuclein</scp> Pathology and Enteric Gliosis in Advanced Parkinson's Disease
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study
α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration
Age at onset in genetic prion disease and the design of preventive clinical trials
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges
Quantifying prion disease penetrance using large population control cohorts
Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium
CSF biomarker variability in the Alzheimer's Association quality control program
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA
The need to unify neuropathological assessments of vascular alterations in the ageing brain